Why the study?
Primary intracranial myxofibrosarcoma is an exceedingly rare mesenchymal malignancy with only a few cases reported.
Case Report (n=1)
No
This case highlights the aggressive nature, potential for cerebrospinal fluid-mediated dissemination, and stepwise histological upgrading of primary intracranial myxofibrosarcoma, emphasizing the need for long-term comprehensive follow-up.
Answers are grounded in this paper and cite their sources.
Alerts clinicians to aggressive recurrence risk in rare intracranial myxofibrosarcoma; leaves open optimal adjuvant strategies pending prospective data.
Primary intracranial myxofibrosarcoma (MFS) is an exceedingly rare mesenchymal malignancy, with only a few cases reported. We report a 34-year-old male with a right frontal lobe MFS who subsequently developed two non-contiguous recurrences in the right temporal and left frontal lobes. Histopathological examination revealed a stepwise progression from low- to intermediate- to high-grade disease, accompanied by progressively increasing Ki-67 labeling indices. Notably, the pattern of spatially separate recurrences suggests the possibility of cerebrospinal fluid-mediated dissemination. This case highlights the aggressive and heterogeneous nature of intracranial MFS and underscores the importance of long-term, comprehensive follow-up to detect recurrences, particularly at non-contiguous sites.
No takes yet. Share an insight, caveat, or question.
Wen et al. (2026) conducted a case report in Primary intracranial myxofibrosarcoma (n=1). Surgical resection and adjuvant radiotherapy was evaluated on Tumor recurrence and histopathological progression.
Synapse has enriched 10 related papers. Consider them for comparative context: